Browsing Clinical Studies by subject "International SU2C/PCF Prostate Cancer Dream Team"
Now showing items 1-1 of 1
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC). (2018-07)<b>Purpose:</b> Persistent androgen receptor (AR) signaling drives castration-resistant prostate cancer (CRPC) and confers resistance to AR-targeting therapies. Novel therapeutic strategies to overcome this are urgently ...